Switch View
© PR Newswire
16.10.2025
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
TECVAYLI® plus DARZALEX FASPRO® combination regimen significantly improves progression-free survival and overall survival versus standard of care
News Preview
First Phase 3 study (MajesTEC-3) of an investigational combination to show benefit in PFS and OS in relapsed/refractory multiple myeloma as early as second line...
Themefolio
Profiler
Peergroup
© Newsfile
16.10.2025
ISIN: CA71716H1082
PharmaTher Holdings Ltd.
PHRM
LISTED
CSE
PharmaTher Advances Phase 3 FDA Package for Ketamine in LID-Parkinson's Disease
News Preview
Company preparing FDA meeting package to align on a single, well-controlled Phase 3 study under 505(b)(2); Pharma partner discussions ongoingToronto, Ontario--(Newsfile Corp. - October 16, 2025) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty life sciences company focused on unlocking the...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US68218J1034
OmniAb Inc
OABI
LISTED
NASDAQ
OmniAb to Participate in Three Investor Conferences in November
News Preview
OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in three investor conferences during the month of November.
2025 Truist Securities BioPharma Symposium, November 6 at the Lotte New York Palace Hotel. Matt Foehr, Chief Executive Officer, will participate in one-on-one meetings with investors on Thursday, November...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
16.10.2025
ISIN: US8835561023
Thermo Fisher Scientific Inc
TMO
LISTED
NYSE
Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI
News Preview
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced plans to further increase the impact of Thermo Fisher’s proven growth strategy through the use of artificial intelligence (AI) with OpenAI. This collaboration will help to improve the speed and success of drug development, enabling customers to get medicines...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
16.10.2025
ISIN: US02043Q1076
Alnylam Pharmaceuticals Inc
ALNY
LISTED
NASDAQ
Alnylam to Webcast Conference Call Discussing Third Quarter 2025 Financial Results
News Preview
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the third quarter ending September 30, 2025 on Thursday, October 30, 2025, before the U.S. financial markets open.
Management will provide an update on the Company and discuss third quarter 2025 results a...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US6323071042
Natera Inc
NTRA
LISTED
NASDAQ
Natera Named to Fast Company’s Next Big Things in Tech List
News Preview
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it has been named to Fast Company’s 2025 Next Big Things in Tech list. Honored for its Signatera personalized molecular residual disease (MRD) test, Natera was one of five companies recognized in the health and medicine category.
This annua...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US4622221004
Ionis Pharmaceuticals Inc
IONS
LISTED
NASDAQ
Ionis to hold third quarter 2025 financial results webcast
News Preview
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Wednesday, October 29th at 11:30 a.m. Eastern Time to discuss its third quarter 2025 financial results and progress on key programs.
The webcast may be accessed at https://ir.ionis.com/events-and-presentations/upcoming-events. A replay will be availabl...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US4576693075
Insmed Inc
INSM
LISTED
NASDAQ
Insmed to Present Multiple Analyses from Phase 3 ASPEN Study at the American College of Chest Physicians Annual Meeting 2025
News Preview
—Data on Structural Lung Changes from a High-Resolution CT Substudy to be Presented as Late-Breaker—
—Additional Analyses Will Highlight Efficacy, Symptom Reduction, and Biomarker Suppression in Patients with Non-Cystic Fibrosis Bronchiectasis—...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US31447E1055
Femasys Inc
FEMY
LISTED
NASDAQ
Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo
News Preview
Will Showcase Latest Fertility Solutions Will Showcase Latest Fertility Solutions...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US3596641098
Fulgent Genetics Inc
FLGT
LISTED
NASDAQ
Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025
News Preview
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its third quarter 2025 financial results before the market opens on Friday, November 7, 2025. Management will host a confere...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US74587B1017
Pulse Biosciences Inc
PLSE
LISTED
NASDAQ
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced that the Compensation Committee of its Board of Directors has granted equity awards to three new employees as equity inducement awards outside of the Co...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US0070021086
Adicet Bio Inc
ACET
LISTED
NASDAQ
Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis (RA)
News Preview
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that the first patient has been dosed in its Phase 1 clinical trial evaluating ADI-001 in treatment-refractory RA.
“Dosing the first patient in our clinical...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
16.10.2025
ISIN: US0758871091
Becton Dickinson and Co
BDX
LISTED
NYSE
BD Looks Ahead to the Next Era of Manufacturing Excellence in Broken Bow, NE and Celebrates 65 Years of Innovation in the Region
News Preview
BROKEN BOW, Neb., Oct. 16, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, proudly commemorates 65 years of manufacturing excellence at its Broken Bow, Nebraska facility—a cornerstone of BD's extensive U.S. manufacturing network....
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
Merck Announces Phase 3 KEYNOTE-B96 Trial Met Secondary Endpoint of Overall Survival (OS) in All Comers Population of Patients With Platinum-Resistant Recurrent Ovarian Cancer
News Preview
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYNOTE-B96 trial, also known as ENGOT-ov65, met its secondary endpoint of overall survival (OS) for the treatment of patients with platinum-resistant recurrent ovarian cancer in all comers. The trial studied KEYTRUDA® (pembrolizumab), Merck’s...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US59503A2042
Microbot Medical Inc.
MBOT
LISTED
NASDAQ
Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting
News Preview
First U.S. Based Medical Meeting Presence Post-FDA Clearance Will Allow the Company to Commercially Engage Future Potential Users of the LIBERTY® System...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: CA98420N1050
Xenon Pharmaceuticals Inc.
XENE
LISTED
NASDAQ
Xenon Announces Appointment of Tucker Kelly as Chief Financial Officer
News Preview
Mr. Kelly is a proven strategic CFO with significant financial, operational and commercialization leadership experience Mr. Kelly is a proven strategic CFO with significant financial, operational and commercialization leadership experience...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US6907321029
Owens & Minor Inc
OMI
LISTED
NYSE
Owens & Minor Announces Date and Time Change of Third Quarter 2025 Financial Results and Conference Call
News Preview
Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the third quarter of 2025 on Thursday, October 30, 2025, after trading ends on the New York Stock Exchange.
The Company will host a conference call for investors and analysts at 5:00 p.m. EDT on the same day. Participants may access the call via the toll-free dial-in numb...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US1374041093
Candel Therapeutics, Inc.
CADL
LISTED
NASDAQ
Candel Therapeutics Appoints Leading Systems Immunology Expert Bali Pulendran, Ph.D., to Research Advisory Board
News Preview
NEEDHAM, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the appointment of Bali Pulendran, Ph.D. to Candel’s Research Advisory Board (RAB)...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US67080T1088
Nuvectis Pharma Inc
NVCT
LISTED
NASDAQ
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
News Preview
Fort Lee, NJ, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT), a clinical stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced upcoming poster presentations for NXP900 at the 2025 AACR-NCI-EORTC...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.10.2025
ISIN: AU000000ANN9
Ansell Ltd
ANN
LISTED
ASX
Ansell Launches Hyflex(TM) Precision Comfort Series with Aerofit(TM) Technology
News Preview
ISELIN, NEW JERSEY / ACCESS Newswire / October 16, 2025 / Ansell Limited (ASX:ANN), a global leader in protection solutions, announced the launch of HyFlex™ Precision Comfort Series with AEROFIT™ Technology, a new line of industrial gloves designed to boost precision and productivity of workers by providing a true second-skin fit for ex...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US12529R1077
C4 Therapeutics Inc
CCCC
LISTED
NASDAQ
C4 Therapeutics Announces Pricing of $125 Million Underwritten Offering
News Preview
$125 Million in Upfront Proceeds Expected to Fund Next Phase of Cemsidomide Multiple Myeloma Development Including Registrational Phase 2 Trial in Combination with Dexamethasone and Phase 1b Trial in Combination with Elranatamab...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US30233G2093
EyePoint Pharmaceuticals Inc
EYPT
LISTED
NASDAQ
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
News Preview
WATERTOWN, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outsid...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US3441741077
Foghorn Therapeutics Inc
FHTX
LISTED
NASDAQ
Foghorn Therapeutics Announces Significant Progress for Selective ARID1B Degrader at the 8th Annual TPD and Induced Proximity Summit
News Preview
Foghorn to host a virtual investor event on updates for its Selective ARID1B, Selective CBP and Selective EP300 degrader programs on Thursday October 30, 2025, at 12 p.m. EDT Foghorn to host a virtual investor event on updates for its Selective ARID1B, Selective CBP and Selective EP300 degrader programs on Thursday October 30, 2025, at 12 p.m. EDT...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US03753U1060
Apellis Pharmaceuticals Inc
APLS
LISTED
NASDAQ
Apellis Pharmaceuticals to Host Conference Call on October 30, 2025, to Discuss Third Quarter 2025 Financial Results
News Preview
Apellis Pharmaceuticals to Host Conference Call on October 30, 2025, to Discuss Third Quarter 2025 F, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its third quarter 2025 financial results on Thursday, October 30, 2025, at 8:30 a.m...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US36269B1052
Gain Therapeutics, Inc.
GANX
LISTED
NASDAQ
Gain Therapeutics to Attend the 2025 Maxim Growth Summit
News Preview
BETHESDA, Md., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced it will participate in the upcoming 2025 Maxim Growth Summit, taking place f...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: CA2059531020
Conavi Medical Corp
CNVI
LISTED
TSX
Conavi Medical to Present at the Planet MicroCap Showcase: TORONTO in partnership with MicroCapClub on Wednesday, October 22, 2025
News Preview
TORONTO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced that it will be presenting at the Planet M...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US00847X1046
Agios Pharmaceuticals Inc
AGIO
LISTED
NASDAQ
Agios to Host Third Quarter 2025 Financial Results Conference Call and Webcast on October 30 at 8:00 a.m. ET
News Preview
Agios today announced the company will host a conference call and live webcast on Thursday, October 30, 2025, at 8:00 a.m. ET to report its third quarter...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US2528281080
Dianthus Therapeutics Inc
DNTH
LISTED
NASDAQ
Dianthus Therapeutics Announces Exclusive License Agreement with Leads Biolabs for DNTH212, a First and Potentially Best-In-Class, Phase 1 Ready Bifunctional BDCA2 & BAFF/APRIL Inhibitor for Severe Autoimmune Diseases
News Preview
DNTH212 is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function ...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US5171251003
Larimar Therapeutics Inc
LRMR
LISTED
NASDAQ
Larimar Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LRMR
News Preview
LOS ANGELES, Oct. 16, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Larimar Therapeutics, Inc. ("Larimar" or "the Company") (NASDAQ: LRMR) for violations of the securities laws.
INVESTIGATION DETAILS: The investigation...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US5171251003
Larimar Therapeutics Inc
LRMR
LISTED
NASDAQ
LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
News Preview
LOS ANGELES, Oct. 16, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Larimar Therapeutics, Inc. ("Larimar" or "the Company") (NASDAQ: LRMR) for violations of the securities laws....
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US05356F1057
Aveanna Healthcare Holdings Inc
AVAH
LISTED
NASDAQ
Aveanna Announces Third Quarter 2025 Earnings Release Date and Conference Call
News Preview
ATLANTA, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its third quarter results before the market open on Thursday, November 6, 2025, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day....
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: US98985Y1082
Zymeworks Inc
ZYME
LISTED
NYSE
Zymeworks to Report Third Quarter 2025 Financial Results and Host Conference Call on November 6, 2025
News Preview
VANCOUVER, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced that...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.10.2025
ISIN: US29350E1047
Enochian Biosciences, Inc
ENOB
LISTED
NASDAQ
Landmark Study Identifies Prognostic Biomarkers in Duchenne Muscular Dystrophy Using Large-Scale Serum Proteomics
News Preview
Published in Nature Communications, a new study uncovers critical protein biomarkers that predict functional decline in Duchenne Muscular Dystrophy (DMD), opening doors to more personalized care and improved clinical trials. LEIDEN, THE NETHERLANDS, GAINESVILLE, FL, AND NEW YORK, NY, CA / ACCESS Newswire / October 16, 2025 / In a major advancement...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.10.2025
ISIN: US29350E1047
Enochian Biosciences, Inc
ENOB
LISTED
NASDAQ
Lunai Bioworks Regains Compliance with Nasdaq Minimum Bid Price Requirement
News Preview
LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 16, 2025 / Lunai Bioworks, Inc. (Nasdaq:LNAI), today announced that it has regained compliance with Nasdaq's minimum bid price requirement.On April 14, 2025, Nasdaq Staff notified the Company that its common stock had failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: SE0022419784
Sectra AB
SECT_B
LISTED
STO
Sectra adds Smith+Nephew 3D templates to its orthopaedic solution--supporting wider adoption of digital surgical planning
News Preview
LINKÖPING, Sweden, Oct. 16, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra(STO: SECT B) has expanded its pre-operative planning solution for orthopaedic trauma cases with 3D templates from one of the world's leading medical equipment companies, Smith+Nephew. Extending the r...
Themefolio
Profiler
Peergroup
© EQS Newswire
16.10.2025
ISIN: FR0013154002
Sartorius Stedim Biotech SA
DIM
LISTED
EURONEXT
Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2025
News Preview
Sartorius Stedim Biotech SA
/ Key word(s): 9 Month figures
Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2025 16-Oct-2025 / 07:00 CET/CEST
Aubagne, France | October 16, 2025
Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2025
Sales revenue reaches 2,195 mi......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.10.2025
ISIN: DE0007165631
Sartorius AG
SRT3
LISTED
XETR
Sartorius schärft Prognose nach deutlich profitablem Umsatzwachstum in den ersten neun Monaten
News Preview
Göttingen, 16. Oktober 2025
Sartorius schärft Prognose nach deutlich profitablem Umsatzwachstum in den ersten neun Monaten
Konzernumsatz steigt in den ersten neun Monaten um 7,5 Prozent
Signifikanter Zuwachs im Wiederholgeschäft mit Verbrauchsmaterialien hält weiter an
Sparte Bioprocess Solutions wächst um rund 10 Prozent; Laborsparte erholt......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.10.2025
ISIN: DE0007165631
Sartorius AG
SRT3
LISTED
XETR
Sartorius sharpens guidance after significantly profitable sales revenue growth in the first nine months
News Preview
Göttingen, Germany | October 16, 2025
Sartorius sharpens guidance after significantly profitable sales revenue growth in the first nine months
Group sales revenue up 7.5 percent in the first nine months
Significant growth in recurring business with consumables continues
Bioprocess Solutions Division grows by around 10 percent, lab division rec......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.10.2025
ISIN: US60770K1079
Moderna, Inc
MRNA
LISTED
NASDAQ
Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
News Preview
CAMBRIDGE, MA, MA / ACCESS Newswire / October 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, November 6, 2025 to report its third quarter 2025 financial results, and provide a corporate update.A live webcast of the call will be available under "Events and...
Themefolio
Profiler
Peergroup
© EQS Newswire
16.10.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Actor Pharmaceuticals and Megalabs become partners for the commercialization of Formycon’s Eylea® biosimilar FYB203 (aflibercept) for Australia and Latin America
News Preview
Press Release // October 16, 2025
Actor Pharmaceuticals and Megalabs become partners for the commercialization of Formycon’s Eylea® biosimilar FYB203 (aflibercept) for Australia and Latin America
Planegg-Martinsried, Germany – Formycon AG (FSE: FYB, “Formycon”) announces that Klinge Biopharma GmbH (“Klinge”), the exclusive owner of the global c......
Themefolio
Profiler
Peergroup
© EQS Newswire
16.10.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Actor Pharmaceuticals und Megalabs werden Vermarktungspartner für Formycons Eylea®-Biosimilar FYB203 (Aflibercept) in Australien und Lateinamerika
News Preview
Pressemitteilung // 16. Oktober 2025
Actor Pharmaceuticals und Megalabs werden Vermarktungspartner für Formycons Eylea®-Biosimilar FYB203 (Aflibercept) in Australien und Lateinamerika
Planegg-Martinsried – Die Formycon AG (FWB: FYB, “Formycon”) gibt bekannt, dass die Klinge Biopharma GmbH (“Klinge”), Lizenznehmer und exklusiver Inhaber der welt......
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: KYG0146B1032
Akeso, Inc.
9926
LISTED
HKSE
HARMONi-6 Phase III Study of Ivonescimab Accepted by The Lancet and Selected for ESMO 2025 LBA Presentation
News Preview
HONG KONG, Oct. 16, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) today announced that the groundbreaking results from the registrational Phase III AK112-306/HARMONi-6 study of ivonescimab have been accepted for publication in The Lancet. The study evaluated ivonescimab, a first-in-class PD-1/VEGF bispecific antibody...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US4523271090
Illumina Inc
ILMN
LISTED
NASDAQ
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
News Preview
At ASHG, an early access customer from the London Health Sciences Center Research Institute demonstrated the power of the 5-base genome for accelerating resolution of rare disease cases
Proprietary 5-base chemistry and novel DRAGEN algorithms enable dual-omic i...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US4523271090
Illumina Inc
ILMN
LISTED
NASDAQ
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
News Preview
At ASHG, an early access customer from the London Health Sciences Center Research Institute demonstrated the power of the 5-base genome for accelerating resolution of rare disease cases
Proprietary 5-base chemistry and novel DRAGEN algorithms enable dual-omic i...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: DK0015998017
Bavarian Nordic A/S
BAVA
LISTED
CPH
The Board of Directors maintains its recommendation in supplementary statement in respect of the improved takeover offer to the shareholders of Bavarian Nordic from the consortium led by Nordic Capital and Permira
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: CH0012032048
Roche Holding AG
ROG
LISTED
SIX
Roche presents major advances for its sequencing by expansion technology(1), including a new GUINNESS WORLD RECORD™, at the ASHG conference 2025
News Preview
Basel, 16 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) presented major updates on its innovative sequencing by expansion (SBX) technology at the American Society of Human Genetics (ASHG) 2025 Annual Meeting in Boston, USA. Following its recent unveiling, SBX is already being recognized by early evaluators in the sequencing community for its co...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.10.2025
ISIN: CH0325814116
Kuros Biosciences AG
KURN
LISTED
SIX
Kuros Biosciences increases the annual guidance for 2025, The company reports 77% year-over-year increase for the first nine months of 2025
News Preview
Ad hoc announcement pursuant to Article 53 of the SIX listing rules...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
Stockholder Alert: Robbins LLP Informs MoonLake Immunotherapeutics Stockholders that a Class Action Lawsuit was Filed Against the Company
News Preview
SAN DIEGO, Oct. 15, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired MoonLake Immunotherapeutics (NASDAQ: MLTX) common stock between March 10, 2024 and September 29, 2025. MoonLake is a Swiss clinical-stage biotechno...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US5171251003
Larimar Therapeutics Inc
LRMR
LISTED
NASDAQ
Larimar Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – LRMR
News Preview
The DJS Law Group announces that it is investigating claims on behalf of investors of Larimar Therapeutics, Inc. (“Larimar” or “the Company”) (NASDAQ: LRMR) for violations of the securities laws.
INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US5171251003
Larimar Therapeutics Inc
LRMR
LISTED
NASDAQ
LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Larimar Therapeutics, Inc. (“Larimar” or “the Company”) (NASDAQ: LRMR) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or fai...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action Investigation - TLX
News Preview
NEW YORK, Oct. 15, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US8753721047
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
News Preview
NEW YORK, Oct. 15, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 15, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lantheus Holdings, Inc. (NASD...
Themefolio
Profiler
Peergroup
© Newsfile
16.10.2025
ISIN: CA00654D1006
Adastra Holdings Ltd.
XTRX
LISTED
CSE
Adastra Holdings Announces Completion of Sale of Subsidiaries
News Preview
Langley, British Columbia--(Newsfile Corp. - October 15, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) (the "Company") announces that it has completed the sale of all of the issued and outstanding shares of its wholly-owned subsidiaries, Adastra Labs Holdings (2019) Ltd. ("Adastra Labs"), 1178562 B.C. Ltd. ("11...
Themefolio
Profiler
Peergroup
© PR Newswire
16.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 15, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purch...
Themefolio
Profiler
Peergroup
© BusinessWire
16.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
Securities Fraud Investigation Into aTyr Pharma Inc. (ATYR) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of aTyr Pharma Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON ATYR PHARMA INC. (ATYR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECO...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: US92337F1075
Veracyte Inc
VCYT
LISTED
NASDAQ
Veracyte to Release Third Quarter 2025 Financial Results on November 4, 2025
News Preview
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will release financial results for the third quarter of 2025 after the close of market on Tuesday, November 4, 2025. Company management will host a conference call and webcast to discuss financial results and provide a general business update at 4:30 p.m....
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: US2288951088
Cryo-Cell International, Inc.
CCEL
LISTED
XASE
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results
News Preview
Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the “Company”, “Cryo-Cell”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2025.
Financial Results
Revenue
Consolidated revenues for the third quarter of fiscal 2025 were $7.83...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2025
ISIN: US40131M1099
Guardant Health Inc
GH
LISTED
NASDAQ
Guardant Health and Collaborators to Present New Data Across the Cancer Care Continuum at ESMO 2025
News Preview
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that new data from across its oncology portfolio will be presented in 15 accepted abstracts at the European Society for Medical Oncology (ESMO) Congress 2025, taking place October 17–21 in Berlin, Germany. These presentations span the cancer care treatment co...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2025
ISIN: US92556V1061
Viatris Inc
VTRS
LISTED
NASDAQ
Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia® in Japan and Certain Other Markets in the Asia-Pacific Region
News Preview
Strengthens Viatris' Presence in Japan With the Addition of Two Innovative Assets Targeting Areas of Significant Unmet Medical Need
Leverages Existing Infrastructure and Expertise in Central Nervous System Therapy Area...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
